AtomVie Global Radiopharma Inc. is a global leader in contract development and manufacturing organisation (CDMO) services, specialising in the Good Manufacturing Practice (GMP) manufacturing and distribution of clinical and commercial radiopharmaceuticals. As a recent spinout from the Centre for Probe Development and Commercialization (CPDC), AtomVie provides a comprehensive suite of scientific, technical, regulatory, quality, logistics, and business expertise combined with a state-of-the-art purpose-built facility for the development of radiotherapeutics from Phase 1 through to the commercial marketplace.

Services include:
- GMP manufacturing of radiopharmaceuticals
- Clinical supply services
- Regulatory compliance assistance
- Quality assurance and quality control
- Logistics and supply chain management
- Business development and market access support

AtomVie Global Radiopharma Inc. is committed to empowering the development of innovative radiopharmaceuticals for its partners in the pharmaceutical industry. For more information, please visit atomvie.com.